Assessment of pharmacotherapy of children with acute obstructive bronchitis at the in patient hospital department according to ABC- and frequency analysis results
Keywords:acute obstructive bronchitis, pediatric patients, clinical and economical analysis, ABC-analysis, frequency analysis
Topicality. Obstructive bronchitis in children refers to diseases that are of important medical and social importance because of the prevalence, the severe course of the disease, the relapse tendency and the high frequency of patients hospitalization.
Aim. To make an assessment of expenditures structure for medicines, which have been prescribed to children with acute obstructive bronchitis at one of the Kharkiv health care institution, and the frequency of their prescriptions.
Materials and methods. Clinical and economic research methods - ABC- and frequency analyses - have been used in the work.
Results and discussion. According to the results of frequency analysis decongestants and other nasals for topical use, preparations for throat, glucocorticoids, antibacterials for systemic use, digestives, including enzymes, antihistamines for systemic use, vitamins, other systemic drugs for obstructive airway diseases, mucolytics most often prescribed to patients have been studied. Carrying out the ABC-analysis it was found that the costs for glucocorticoids, antibacterials for systemic use and decongestants and other nasals for topical use have been accounted for most of the costs of pharmacotherapy of children with acute obstructive bronchitis.Conclusions. The dominant pharmacotherapy of pediatric patients with acute obstructive bronchitis in this Kharkiv health care institution is the pathogenetic and symptomatic therapy of underlying and concomitant diseases. The main cost related to the pharmacotherapy of the patients studied was spent on drugs, which most often prescribed for acute obstructive bronchitis and concomitant pathology treatment.
Senatorova, H. S., Bashkirova, N. V., Strelkova, M. I. (2017). Optymizatsiia dyferentsialnoi diahnostyky ta likuvannia ditei iz syndromom bronkhialnoi obstruktsii. Zdorov´ia Ukrainy, 1, 3–5.
Zhukova, O. V., & Kononova, S. V. (2016). Method “cost-effectiveness” in evaluetion of atibiotic treatment of acytr obstructive bronchitis in children in hospital. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology, 9 (3), 30–37. https://doi.org/10.17749/2070-4909.2016.9.3.030-037
Samal, T., Maskalenko, T. (2013). Lechenye obstruktyvnыkh form ostroho bronkhyta u detei ranneho vozrasta. Nauka y ynnovatsyy, 3(121), 66–70.
Koreniuk, O. S. (2014). Osoblyvosti terapii hostroho obstruktyvnoho bronkhitu u ditei rannoho viku. Aktualni pytannia pediatrii, akusherstva ta hinekolohii, 2, 50–53.
Bokonbaeva, S. D., & Apsamatova, N. M. (2017). Features clinical of a current it is bronchial obstruction at children of early age. Neonatology, Surgery and Perinatal Medicine, 7 (3 (25)), 63–67. https://doi.org/10.24061/2413-4260.vii.3.25.2017.10
Gibsona, Dzh., Loddenkempera, R., Sibilia, Ivs., Lundbeka, Bo., Fletcher, M. (Eds.). (2013). Zdorove legkikh v Evrope. Fakty i tcifry. Available at: https://www.europeanlung.org/assets/files/publications/russian_lung_health_in_europe_facts_and_figures.pdf
Morozov, A. M., Yakovlieva, L. V., Bezditko, N. V., Mishchenko, O. Ya., Zimenkovskyi, A. B., Stepanenko, A. V., Parii, A. D., ... Adonkina, V. Yu. (2013). Otsinka klinichnoi ta ekonomichnoi dotsilnosti vykorystannia likarskykh zasobiv u likuvalno-profilaktychnomu zakladi (suprovid formuliarnoi systemy): metod. rek. Kharkiv: Styl-Yzdat, 36.
Yakovlieva, L. V. (Ed). (2017). Farmakoekonomika: navch. posib. dlia stud. VNZ (2nd-edition). Vinnytsia: NOVA KNYHA, 208.
Kuprash, L. P., Hrinenko, Yu. O. (2014). Farmakoekonomichnyi analiz medykamentoznoi terapii v umovakh statsionaru. Ratsyonalnaia farmakoterapyia, 3 (32), 17–20.
Kompendyum OnLine: dovidnyk. (n.d.). Available at: https://compendium.com.ua/prices/
Copyright (c) 2020 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).